Patent AT-E401075-T1: [Translated] MEDICINAL PRODUCT CONTAINING CYTISINE
The invention relates to a cytisine containing solid dosage form for oral administration. It helps achieve an even distribution of the active substance throughout the tablet mass. The resulting tablets possess high mechanical strength, high solubility of cytisine and good disintegration. This is achieved through appropriate lactose and microcrystal cellulose ratios and contents of the cytisine tablets.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[
"009:25"
]
|
| contactPoint |
{
"fn": "NIH/NCBI Data Team",
"@type": "vcard:Contact",
"hasEmail": "mailto:info@ncbi.nlm.nih.gov"
}
|
| description | The invention relates to a cytisine containing solid dosage form for oral administration. It helps achieve an even distribution of the active substance throughout the tablet mass. The resulting tablets possess high mechanical strength, high solubility of cytisine and good disintegration. This is achieved through appropriate lactose and microcrystal cellulose ratios and contents of the cytisine tablets. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Official Data Source",
"mediaType": "text/html",
"description": "Access the complete Patent AT-E401075-T1: [Translated] MEDICINAL PRODUCT CONTAINING CYTISINE on the official website.",
"downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E401075-T1"
}
]
|
| identifier | https://healthdata.gov/api/views/hxfs-zsen |
| issued | 2025-09-05 |
| keyword |
[
"chemistry",
"innovation",
"patent",
"pubchem",
"research"
]
|
| landingPage | https://healthdata.gov/d/hxfs-zsen |
| modified | 2025-09-06 |
| programCode |
[
"009:066"
]
|
| publisher |
{
"name": "National Center for Biotechnology Information (NCBI)",
"@type": "org:Organization"
}
|
| theme |
[
"NIH"
]
|
| title | Patent AT-E401075-T1: [Translated] MEDICINAL PRODUCT CONTAINING CYTISINE |
